LONDON, Sept. 19, 2026 /PRNewswire/ -- Hainan Airlines, part of HNA Aviation Group, was named a SKYTRAX Five-Star Airline for the 15th consecutive year at the 2026 World Airline Awards ceremony in London on Sept. 18, in recognition of its consistently high-quality products and services. The airline also ranked among the Skytrax World's Best Airlines Top 10 List and earned top honors in several global and regional categories, including Best Airline in China, Best Airline Staff Service in China and Best Business Class Airline Comfort Amenities. Zhu Tao, Vice President of HNA Aviation Group and Chairman of Hainan Airlines, attended the ceremony.

Edward Plaisted, CEO of SKYTRAX, congratulated Hainan Airlines on retaining its Five-Star Airline rating for the 15th consecutive year. In 2026, Hainan Airlines once again ranked among the world's top 10 airlines and placed fourth in the World's Best Cabin Crew category, reflecting its growing standing in the international aviation industry.

"We are greatly honored to receive three prestigious awards from SKYTRAX," said Zhu Tao, Vice President of HNA Aviation Group and Chairman of Hainan Airlines. "These accolades are high recognition of Hainan Airlines' service quality and product innovation, and represent the combined achievements of our dedicated workforce and the enduring trust of our passengers. As a SKYTRAX 5‑Star Airline, we will remain passenger‑centric, continuously elevate our service standards and product experience, and further advance service innovation. We strive to deliver more comfortable, convenient and heartfelt travel experiences for passengers across the globe. These awards will drive us forward. Benchmarking against higher standards, we will refine our premium aviation services and work to create an even better in‑flight journey for travelers worldwide."

Hainan Airlines continues to expand its international network, which now spans Asia, Europe, Africa, North America and Oceania. To date, its international and regional network comprises more than 70 routes on which service has resumed or begun, or is scheduled to begin. At the same time, the airline continues to optimize its domestic network and express services. Its Premium Express network has expanded to nine routes, while its Free Trade Port Express network now includes six, providing business and frequent travelers with a more efficient and convenient experience throughout their journey.

The airline is also expanding its connecting services. Streamlined ground services for itineraries involving international and regional connections are now available at major national and regional aviation hubs, including Beijing, Shenzhen, Chongqing, Haikou, Xi'an, Changsha, Chengdu Tianfu, Shanghai Pudong and Guangzhou. The number of domestic departure points covered by these services has increased from 19 to 36, encompassing 21 provincial capitals, three municipalities, three autonomous-region capitals and several other key passenger markets. The number of departure points outside mainland China has increased to 41.

Hainan Airlines builds its five‑star service brand anchored in three core values: cultural experience, beyond expectation and humanity, represented by three exclusive sub‑brands DREAM, HAI and CARE respectively. The DREAM series delivers premium lounge cultural experience, covering self‑operated lounges in Beijing, Haikou, Hangzhou, Urumqi and Taiyuan, partner lounges in Guangzhou and Shenzhen, an upcoming partner lounge in Chongqing, and a distinctive co‑branded lounge in Shanghai jointly developed with IHG. The HAI series focuses on exceeding passenger expectations via efficient ground services including HAI‑PASS, global self‑check‑in and seamless interline transfers with baggage through‑check. The CARE series embodies humanized travel philosophy with tailored pet‑friendly cabin travel solutions. All optimized ground services jointly create a refined and thoughtful travel journey for passengers.

In addition, Hainan Airlines continues to build partnerships with leading premium brands and explore regional culinary traditions as it upgrades every aspect of its in-flight dining program and further enhances its five-star service. Renewing its partnership with IHG Hotels & Resorts, the airline has teamed up with Cai Feng Lou at HUALUXE Xi'an Tanghua to introduce "Dining Above the Clouds: Finest Flavors from North and South," a collaborative menu that brings the culinary traditions of the ancient capital of Xi'an on board. Hainan Airlines has also continued to refine its in-flight beverage program and update its drinks menu, offering a carefully selected range of premium beverages and a wider variety of choices for passengers.

Looking ahead, Hainan Airlines will maintain its unwavering commitment to safety and service. The airline will continue to develop new service offerings, improve its service processes and refine every detail of the passenger experience. By combining elements of Eastern culture with modern airline service, Hainan Airlines will continue to strengthen its international capabilities and provide passengers worldwide with a safer, more comfortable, convenient and enjoyable five-star travel experience. It will also continue supporting the development of the Hainan Free Trade Port and the continued modernization and growth of China's civil aviation industry.

For more information, please visit:

Official websites: www.hnair.com or www.hainanairlines.com

Weibo: https://www.weibo.com/hnair

WeChat: HNairlines

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/hainan-airlines-retains-skytrax-five-star-rating-for-15th-consecutive-year-and-ranks-among-the-skytrax-worlds-best-airlines-top-10-list-302883809.html

Roche versucht nach einer Phase von Forschungsrückschlägen und Belastungen durch auslaufende Patente, das Tempo in der Medikamentenentwicklung deutlich zu erhöhen. Am Pharma-Investorentag unterstrich die Pharmasparte des Basler Konzerns den Anspruch, in Forschung und Entwicklung weiter zur Spitzengruppe zu gehören. Zentral sind dabei ein strengeres Management der Pipeline, Effizienzprogramme und der verstärkte Einsatz künstlicher Intelligenz entlang der Wertschöpfungskette.

Pharma-Chefin Teresa Graham verwies auf eine sichtbar verbesserte Bilanz seit dem letzten „Pharma Day“: In zehn zulassungsrelevanten Studien habe Roche die gesetzten Ziele erreicht, sechs Programme seien in die zulassungsrelevende Phase vorgerückt, drei weitere in Phase II. Insgesamt verfügt Roche nach eigenen Angaben über bis zu 20 neue Wirkstoffe, die bis 2030 auf den Markt kommen könnten. Einzelne Kandidaten wie das Brustkrebsmittel Giredestrant traut der Konzern dabei jeweils Spitzenumsätze im zweistelligen Milliardenbereich zu.

Um diese Ambitionen abzusichern, verschärft Roche die internen Selektionskriterien. Ende 2023 führte der Konzern mit „The Bar“ einen neuen Bewertungsrahmen für die Pipeline ein. Nur Wirkstoffkandidaten, die klar definierte Anforderungen erfüllen, werden weiterentwickelt. Medizinchef Levi Garraway bezeichnete „The Bar“ als Leitbild für Forschung und Entwicklung. Die Auswahl potenzieller Projekte sei damit spürbar strenger geworden – mit dem Ziel, Ressourcen konsequent auf die Erfolg versprechendsten Programme zu konzentrieren und die Erfolgsquote in späten Studienphasen zu stabilisieren oder weiter zu erhöhen.

Parallel dazu treibt Roche ein Effizienzprogramm voran, um Mittel aus weniger renditestarken in wachstumsstärkere Projekte umzuschichten. Die Entwicklung neuer Medikamente soll deutlich beschleunigt werden, was insbesondere in umkämpften Indikationen wie Onkologie sowie in wachstumsstarken Bereichen wie Herz-Kreislauf- und Stoffwechselerkrankungen an Bedeutung gewinnt. Damit will Roche erwartete Umsatzeinbussen durch Patentabläufe mehr als kompensieren und sich bis zum Ende des Jahrzehnts ein Portfolio aufbauen, das von mehreren potenziellen Blockbustern getragen wird.